Fine particulate matter (PM2.5):The culprit for chronic lung diseases in China
- Author:
Li TAO
1
;
Hu RONG
;
Chen ZI
;
Li QIYUAN
;
Huang SHOUXIONG
;
Zhu ZHOU
;
Zhou LIN-FU
Author Information
1. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China
- Publication Type:Journal Article
- Keywords:
Air pollution;
Particulate matter;
Lung diseases;
Chronic obstructive pulmonary disease
- From:
Chronic Diseases and Translational Medicine
2018;4(3):176-186
- CountryChina
- Language:English
-
Abstract:
Air pollution is a world public health problem. Particulate matter (PM), a mix of solid and liquid particles in the air, becomes an increasing concern in the social and economic development of China. For decades, epidemiological studies have confirmed the association between fine particle pollutants and respiratory diseases. It has been reported in different populations that increased fine particulate matter (PM2.5) concentrations cause elevated susceptibility to respiratory diseases, including acute respiratory distress, asthma, chronic obstructive pulmonary disease, and lung cancer. This review will discuss the pathophysiology of PM2.5 in res-piratory diseases, which are helpful for the prevention of air pollution and treatment of respiratory tract inflammatory diseases.
